The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
CALATLANTIC GROUP INC | COM | 128195104 | 13,463 | 238,742 | SH | SOLE | 238,742 | 0 | 0 | ||
CLIFTON BANCORP INC | COM | 186873105 | 1,963 | 114,821 | SH | SOLE | 114,821 | 0 | 0 | ||
IGNYTA INC | COM | 451731103 | 3,700 | 138,587 | SH | SOLE | 138,587 | 0 | 0 | ||
IGNYTA INC | COM | 451731103 | 2,782 | 104,200 | SH | Put | SOLE | 104,200 | 0 | 0 | |
MAINSOURCE FINANCIAL GP INC | COM | 56062Y102 | 1,051 | 28,945 | SH | SOLE | 28,945 | 0 | 0 | ||
SCRIPPS NETWORKS INTERACT IN | CL A COM | 811065101 | 1,754 | 20,542 | SH | SOLE | 20,542 | 0 | 0 | ||
SNYDERS-LANCE INC | COM | 833551104 | 776 | 15,500 | SH | SOLE | 15,500 | 0 | 0 | ||
STRAIGHT PATH COMMUNICATNS I | CL B | 862578101 | 4,787 | 26,333 | SH | SOLE | 26,333 | 0 | 0 | ||
STRAIGHT PATH COMMUNICATNS I | CL B | 862578101 | 1,763 | 9,700 | SH | Put | SOLE | 9,700 | 0 | 0 | |
SUCAMPO PHARMACEUTICALS INC | CL A | 864909106 | 1,778 | 99,028 | SH | SOLE | 99,028 | 0 | 0 | ||
SUCAMPO PHARMACEUTICALS INC | CL A | 864909106 | 314 | 17,500 | SH | Put | SOLE | 17,500 | 0 | 0 |